Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The quick ratio (acid-test) is N/A as of Tuesday, October 6, 2026.
QUICK RATIO (ACID-TEST)
N/A
Market Cap
$137.57M
Quick Ratio (Acid-Test)
2.09
TTM Avg
2.13
3Y Avg
2.85
5Y Avg
4.38
Market Cap
$140.09M
Quick Ratio (Acid-Test)
8.04
TTM Avg
11.45
3Y Avg
6.05
5Y Avg
5.52
Market Cap
$139.95M
Quick Ratio (Acid-Test)
0.79
TTM Avg
0.57
3Y Avg
0.67
5Y Avg
0.95
Market Cap
$141.70M
Quick Ratio (Acid-Test)
3.83
TTM Avg
1.68
3Y Avg
1.58
5Y Avg
2.46
Market Cap
$144.79M
Quick Ratio (Acid-Test)
19.47
TTM Avg
11.39
3Y Avg
11.91
5Y Avg
15.23
Market Cap
$131.16M
Quick Ratio (Acid-Test)
2.70
TTM Avg
1.66
3Y Avg
3.23
5Y Avg
3.69
Market Cap
$146.71M
Quick Ratio (Acid-Test)
0.82
TTM Avg
5.49
3Y Avg
4.19
5Y Avg
4.19
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Freenome, Inc. (FRNM) | $138.47M | N/A | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.57M | 2.09 | 2.13 | 2.85 | 4.38 |
| Alpha Cognition Inc (ACOG)vs › | $140.09M | 8.04 | 11.45 | 6.05 | 5.52 |
| AirSculpt Technologies, Inc. (AIRS)vs › | $139.95M | 0.79 | 0.57 | 0.67 | 0.95 |
| LifeMD, Inc. (LFMD)vs › | $135.83M | 0.84 | 0.97 | 0.83 | 1.00 |
| Fortress Biotech, Inc. (FBIOP)vs › | $141.70M | 3.83 | 1.68 | 1.58 | 2.46 |
| Immuneering Corporation (IMRX)vs › | $144.79M | 19.47 | 11.39 | 11.91 | 15.23 |
| Health Catalyst, Inc. (HCAT)vs › | $131.16M | 2.70 | 1.66 | 3.23 | 3.69 |
| Korsana Biosciences, Inc. (KRSA)vs › | $146.71M | 0.82 | 5.49 | 4.19 | 4.19 |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $148.07M | 2.47 | 5.26 | 13.15 | 16.36 |
Quick Ratio
N/A
Excludes inventory
Current Ratio
N/A
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
